Abstract
BCT and mastectomy demonstrate similar survival rates in a trial in which the great majority of the patients had stage II breast cancer.
Keywords
MeSH Terms
Affiliated Institutions
Related Publications
Factors that influence surgical choices in women with breast carcinoma
Abstract BACKGROUND In the absence of medical contraindications, survival after undergoing breast‐conserving therapy (BCT), mastectomy (M), and mastectomy with immediate reconst...
Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials
<p><strong>Background</strong>\nRandomized trials of radiotherapy and surgery for early breast cancer may have been too small to detect differences in long-ter...
Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast Cancer
Five years of adjuvant tamoxifen is more beneficial than 2 years in the treatment of postmenopausal women with estrogen receptor-positive, early stage, invasive breast cancer.
Breast Cancer Treatment
Breast cancer consists of 3 major tumor subtypes categorized according to estrogen or progesterone receptor expression and ERBB2 gene amplification. The 3 subtypes have distinct...
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Some months of adjuvant polychemotherapy (eg, with CMF or an anthracycline-containing regimen) typically produces an absolute improvement of about 7-11% in 10-year survival for ...
Publication Info
- Year
- 2000
- Type
- article
- Volume
- 92
- Issue
- 14
- Pages
- 1143-1150
- Citations
- 1255
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1093/jnci/92.14.1143
- PMID
- 10904087